The Active Pharmaceutical Ingredients market comprises the largest segment of the Indian pharmaceutical sector. India is the third-largest Pharmaceutical APIs market in Asia-Pacific. As per the BusinessWire report, the Indian API Market stood at USD 11806.93 million in FY 2021 and will grow at a CAGR of 12.24% during the forecast period. The Indian API Market is segmented based on the synthesis, source, therapeutic application, drug type, company, and region. Out of the various therapeutic categories, we will discuss 11 trending therapeutic categories of APIs and their uses. All the therapeutic categories, pharmacologic class, and formulary key drug types are available on the FDA website, and their scientific definitions are available on the Britannica website. However, we have delineated some of the most prominent APIs that rule the markets and are always in demand.
Rephine says its online Quality Assurance database transforms the lengthy active pharmaceutical ingredient (API) pre-selection process to just a couple of clicks.